Levofloxacin is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain bacterial infections, including community-acquired pneumonia, acute worsening of chronic bronchitis, anthrax, urinary tract infections, acute sinus infections, and others. Community-acquired pneumonia, a bacterial respiratory infection, can be an opportunistic infection (OI) of HIV. It is grouped under the following drug class(es): Fluoroquinolones, QTc-prolonging agents, Quinolones and Topoisomerase inhibitors. Its therapeutic use is listed as anti-infectives, antibacterials, antibiotics, antituberculars and ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Levaquin, Quixin, (-)-Ofloxacin and Iquix. Its PubChem CID is 149096.
Levofloxacin
| CAS No | 100986-85-4 |
|---|---|
| Molecular Formula | C18H20FN3O4 |
| Molecular Weight | 361.40 g/mol |
| Synonyms | (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) for the treatment of certain bacterial infections, including community-acquired pneumonia, acute worsening of chronic bronchitis, anthrax, urinary tract infections, acute sinus infections, and others.
The listed CAS number is 100986-85-4.
The listed molecular formula is C18H20FN3O4.
The listed molecular weight is 361.40 g/mol.
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid.
The source lists Levaquin, Quixin, (-)-Ofloxacin and Iquix.